Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

被引：0
|
作者：
Weiwei Huang
Chenxi Wang
Yangkun Shen
Qi Chen
Zhijian Huang
Jian Liu
Xiaoyan Lin
Lili Wang
Fan Wu
Xinhua Chen
Nani Li
Yi Hong
Mulan Chen
Jieyu Li
Chuanzhong Huang
机构：
[1] Fujian Medical University Union Hospital,Department of Medical Oncology
[2] Clinical Oncology School of Fujian Medical University,Department of Medical Oncology
[3] Fujian Cancer Hospital,Fujian Key Laboratory of Translational Cancer Medicine
[4] Fujian Cancer Hospotial,Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China
[5] Fujian Normal University Qishan Campus,Department of Breast Surgical Oncology
[6] Clinical Oncology School of Fujian Medical University,Laboratory of Immuno
[7] Fujian Cancer Hospital,Oncology
[8] Clinical Oncology School of Fujian Medical University,undefined
[9] Fujian Cancer Hospital,undefined
来源：
BMC Cancer | / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study
    Miaomiao Gou
    Haiyan Si
    Yong Zhang
    Niansong Qian
    Zhikuan Wang
    Weiwei Shi
    Guanghai Dai
    Scientific Reports, 8
  • [42] Efficacy and safety of apatinib in patients with previously treated metastatic colorectal cancer: a real-world retrospective study
    Gou, Miaomiao
    Si, Haiyan
    Zhang, Yong
    Qian, Niansong
    Wang, Zhikuan
    Shi, Weiwei
    Dai, Guanghai
    SCIENTIFIC REPORTS, 2018, 8
  • [43] Evaluating the efficacy of adjuvant capecitabine in triple-negative breast cancer patients with residual disease: A real-world evidence study
    Kim, M. J.
    Kim, H. J.
    Park, S.
    Park, Y. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S290 - S290
  • [44] An initial safety study of gedatolisib plus cofetuzumab pelidotin for metastatic triple-negative breast cancer
    Radovich, Milan
    Solzak, Jeffrey P.
    Hancock, Bradley A.
    Badve, Sunil
    Storniolo, Anna Maria V.
    Ballinger, Tarah J.
    Schneider, Bryan P.
    Miller, Kathy D.
    CANCER RESEARCH, 2021, 81 (04)
  • [45] Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World Study
    Mattar, Andre
    Antonini, Marcelo
    Amorim, Andressa Goncalves
    Teixeira, Marina Diogenes
    de Resende, Cristiano Augusto Andrade
    Cavalcante, Francisco Pimentel
    Zerwes, Felipe
    Arakelian, Renata
    Millen, Eduardo de Camargo
    Brenelli, Fabricio Palermo
    Frasson, Antonio Luiz
    Leite, Renata Montarroyos
    Gebrim, Luiz Henrique
    JCO GLOBAL ONCOLOGY, 2025, 11
  • [46] Real-world treatment and survival outcomes in previously untreated patients with metastatic triple-negative breast cancer (mTNBC) in the United States (US)
    Punie, K.
    Kurian, A.
    Ntalla, I.
    Huynh, D. H.
    Sadetsky, N.
    Estrin, A.
    Dabrowski, E.
    Sjekloca, N.
    Lai, C.
    Hurvitz, S. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S347 - S348
  • [47] Real-world outcomes of systemic therapy for advanced triple-negative breast cancer: a tertiary centre experience
    Zhang, Shuai
    Coriano, Matilde
    Mac Eochagain, Colm
    Yang, Dorothy
    Yiu, Daniel
    Ring, Alistair
    Battisti, Nicolo M. L.
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Assessing racial differences in patients with metastatic triple-negative breast cancer: Real-world evidence from US community oncology practices
    Tan, Amie
    Shen, Vincent
    Preger, Luciana
    Day, Bann-mo
    Mitchell, Edith P.
    CANCER RESEARCH, 2021, 81 (04)
  • [49] Understanding real-world treatment and outcomes in patients diagnosed with metastatic triple negative breast cancer (mTNBC).
    Skinner, Karen E.
    Walker, Mark S.
    Haiderali, Amin
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population
    Diaz-Acedo, Rocio
    Artacho Criado, Silvia
    Jimenez Galan, Rocio
    Gutierrez Pizarraya, Antonio
    Galvan Banqueri, Mercedes
    Rodriguez-de-la-Borbolla-Artacho, Maria
    Marcos Rodriguez, Jose Antonio
    Marquez Saavedra, Esther
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) : 1573 - 1582
12345